Nuveen Asset Management LLC Acquires 63,741 Shares of Ryan Specialty Holdings, Inc. (NYSE:RYAN)

Nuveen Asset Management LLC lifted its stake in shares of Ryan Specialty Holdings, Inc. (NYSE:RYAN - Free Report) by 22.1% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 352,516 shares of the company's stock after purchasing an additional 63,741 shares during the quarter. Nuveen Asset Management LLC owned about 0.13% of Ryan Specialty worth $22,617,000 at the end of the most recent quarter.

Several other large investors also recently bought and sold shares of the company. Barclays PLC grew its holdings in Ryan Specialty by 1.1% in the 3rd quarter. Barclays PLC now owns 1,641,743 shares of the company's stock valued at $108,994,000 after buying an additional 17,267 shares during the period. Embree Financial Group grew its position in shares of Ryan Specialty by 64.1% in the 4th quarter. Embree Financial Group now owns 83,212 shares of the company's stock worth $5,339,000 after acquiring an additional 32,500 shares in the last quarter. KBC Group NV lifted its holdings in Ryan Specialty by 1,803.6% in the fourth quarter. KBC Group NV now owns 46,181 shares of the company's stock worth $2,963,000 after acquiring an additional 43,755 shares during the last quarter. Mutual of America Capital Management LLC lifted its position in Ryan Specialty by 1.7% in the 4th quarter. Mutual of America Capital Management LLC now owns 56,203 shares of the company's stock valued at $3,606,000 after purchasing an additional 914 shares during the last quarter. Finally, Truist Financial Corp grew its stake in shares of Ryan Specialty by 7.2% in the fourth quarter. Truist Financial Corp now owns 5,688 shares of the company's stock worth $365,000 after purchasing an additional 381 shares in the last quarter. Institutional investors and hedge funds own 84.82% of the company's stock.

Ryan Specialty Price Performance

Ryan Specialty stock traded down $1.13 during mid-day trading on Wednesday, reaching $69.11. The company had a trading volume of 275,560 shares, compared to its average volume of 982,451. Ryan Specialty Holdings, Inc. has a fifty-two week low of $52.34 and a fifty-two week high of $77.16. The business has a fifty day simple moving average of $70.01 and a 200 day simple moving average of $68.76. The company has a current ratio of 1.01, a quick ratio of 1.01 and a debt-to-equity ratio of 2.40. The company has a market cap of $18.14 billion, a P/E ratio of 100.44, a P/E/G ratio of 1.19 and a beta of 0.68.

Ryan Specialty (NYSE:RYAN - Get Free Report) last issued its quarterly earnings results on Thursday, May 1st. The company reported $0.39 earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of $0.39. The firm had revenue of $690.17 million for the quarter, compared to the consensus estimate of $680.80 million. Ryan Specialty had a net margin of 9.14% and a return on equity of 48.01%. The company's revenue for the quarter was up 25.0% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.35 EPS. On average, equities research analysts predict that Ryan Specialty Holdings, Inc. will post 2.29 earnings per share for the current year.

Ryan Specialty Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, May 27th. Stockholders of record on Tuesday, May 13th were paid a $0.12 dividend. The ex-dividend date of this dividend was Tuesday, May 13th. This represents a $0.48 annualized dividend and a dividend yield of 0.69%. Ryan Specialty's payout ratio is 141.18%.

Insiders Place Their Bets

In other Ryan Specialty news, EVP Brendan Martin Mulshine sold 30,000 shares of Ryan Specialty stock in a transaction that occurred on Friday, March 14th. The shares were sold at an average price of $69.30, for a total transaction of $2,079,000.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 52.21% of the company's stock.

Analyst Upgrades and Downgrades

RYAN has been the subject of a number of recent research reports. Royal Bank of Canada cut their price objective on Ryan Specialty from $73.00 to $72.00 and set a "sector perform" rating for the company in a research report on Friday, February 21st. TD Cowen initiated coverage on Ryan Specialty in a research report on Thursday, April 10th. They set a "buy" rating and a $89.00 price objective for the company. Keefe, Bruyette & Woods dropped their price target on shares of Ryan Specialty from $76.00 to $75.00 and set an "outperform" rating on the stock in a research note on Wednesday, April 9th. Morgan Stanley upped their target price on Ryan Specialty from $78.00 to $80.00 and gave the stock an "overweight" rating in a research report on Monday, May 19th. Finally, The Goldman Sachs Group upgraded Ryan Specialty from a "neutral" rating to a "buy" rating and upped their price target for the stock from $74.00 to $81.00 in a report on Tuesday, May 13th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and eight have issued a buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $75.58.

About Ryan Specialty

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.